CDH1 and prostate adenocarcinoma: In this study, we aimed to identify EMT-related miRNA signatures in prostate adenocarcinoma through comprehensive bioinformatic analysis, validate their interactions with core EMT genes (e.g., CDH1, CDH2, SNAI1, ZEB1, ZEB2), and evaluate their potential as diagnostic or prognostic biomarkers.